Press Releases

NEW YORK, Jan. 31, 2020 /PRNewswire/ -- For the second consecutive year, CipherHealth has been named the #1 vendor for

Read more...

DALLAS, Jan. 31, 2020 /PRNewswire/ -- PELITAS ("the Company"), a leading provider of healthcare Patient Access technology solutions, announced today that it has been recognized as 2020 Best in KLAS® for the

Read more...

CHICAGO, Jan. 31, 2020 /PRNewswire/ -- The Chartis Group, a leading provider of advisory and analytics services to the healthcare industry, received the top ranking in the "

Read more...

NEW YORK, Jan. 31, 2020 /PRNewswire/ -- Ambra Health, makers of the leading cloud-based, medical image management suite, today announced its recognition as the

Read more...

MARLBOROUGH, Mass. and BERLIN, Jan. 31, 2020 /PRNewswire/ -- Candela Corporation, a leading global medical aesthetic device company, has entered into an exclusive collaboration agreement with MT.DERM GmbH for the commercialization of MT.DERM's medical microneedling products.  Under the terms of the agreement, Candela will comme

Read more...

Good Manufacturing Practices PHARMA (GMP-PHARMA) Certification Provides Ikänik with the Ability to Export Pharmaceutical Grade Finished Cannabis Extract to European Markets BOGOTA, Colombia, Jan. 31, 2020 /PRNewswire/ - Ikänik Farms, Inc. (the "Company" or "Ikänik") is pleased to announce that Pideka SAS ("Pideka"), a wholly

Read more...

SEATTLE, Jan. 31, 2020 /PRNewswire/ -- RealSelf, the go-to destination for making cosmetic treatment decisions and connecting with doctors, today announced the 2020 Most Worth It Ranking—a c

Read more...

NEW YORK, Jan. 31, 2020 /PRNewswire/ -- Royalty Pharma, the largest acquiror of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, announced today that George Grofik has been appointed Senior Vice President, Head of Investor Relations and Communications.George brings two decade

Read more...

PRINCETON, N.J., Jan. 31, 2020 /PRNewswire/ -- Kyowa Kirin, Inc., (Kyowa Kirin, TSE: 4151) announces the final safety data from the MAVORIC (Mogamulizumab anti-CCR4 Antibody Versus ComparatOR In CTCL) trial of mogamulizumab-kpkc, which will be presented today at the 12th Annual T-Cell Lymphoma Forum (TCLF) in La Jolla, California.

Read more...

CHICAGO and LOUISVILLE, Ky., Jan. 31, 2020 /PRNewswire/ -- Waystar, a leading provider of revenue cycle technology, received top honors in the

Read more...